Wells Fargo & Company Cerus Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Cerus Corp stock. As of the latest transaction made, Wells Fargo & Company holds 94,022 shares of CERS stock, worth $156,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,022
Previous 101,342 7.22%
Holding current value
$156,076
Previous $178,000 8.43%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1.7 - $2.39 $12,444 - $17,494
-7,320 Reduced 7.22%
94,022 $163,000
Q2 2024

Aug 13, 2024
BUY
$1.62 - $2.04 $10,466 - $13,180
6,461 Added 6.81%
101,342 $178,000
Q1 2024

May 10, 2024
BUY
$1.66 - $2.42 $24,961 - $36,389
15,037 Added 18.83%
94,881 $179,000
Q4 2023

Feb 09, 2024
BUY
$1.25 - $2.35 $16,938 - $31,844
13,551 Added 20.44%
79,844 $172,000
Q3 2023

Nov 13, 2023
SELL
$1.5 - $3.07 $61,876 - $126,640
-41,251 Reduced 38.36%
66,293 $107,000
Q2 2023

Aug 15, 2023
BUY
$1.79 - $2.9 $75,360 - $122,092
42,101 Added 64.33%
107,544 $264,000
Q1 2023

May 12, 2023
BUY
$2.65 - $3.81 $107,423 - $154,445
40,537 Added 162.76%
65,443 $194,000
Q4 2022

Feb 13, 2023
SELL
$3.38 - $4.22 $50,730 - $63,337
-15,009 Reduced 37.6%
24,906 $90,000
Q3 2022

Nov 14, 2022
SELL
$3.43 - $5.83 $34,783 - $59,122
-10,141 Reduced 20.26%
39,915 $144,000
Q2 2022

Aug 12, 2022
SELL
$4.41 - $5.69 $305,661 - $394,379
-69,311 Reduced 58.07%
50,056 $266,000
Q1 2022

May 16, 2022
SELL
$4.81 - $6.99 $267,724 - $389,063
-55,660 Reduced 31.8%
119,367 $655,000
Q4 2021

Feb 14, 2022
BUY
$5.97 - $7.93 $505,056 - $670,870
84,599 Added 93.55%
175,027 $1.19 Million
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $219,022 - $305,443
45,725 Added 102.29%
90,428 $552,000
Q2 2021

Aug 16, 2021
SELL
$5.35 - $6.35 $1.12 Million - $1.33 Million
-209,407 Reduced 82.41%
44,703 $264,000
Q1 2021

May 13, 2021
SELL
$5.68 - $7.87 $654,284 - $906,553
-115,191 Reduced 31.19%
254,110 $1.53 Million
Q4 2020

Feb 09, 2021
SELL
$5.25 - $8.56 $107,866 - $175,873
-20,546 Reduced 5.27%
369,301 $2.56 Million
Q3 2020

Nov 05, 2020
SELL
$5.78 - $7.47 $115,808 - $149,668
-20,036 Reduced 4.89%
389,847 $2.44 Million
Q2 2020

Aug 13, 2020
BUY
$4.5 - $7.02 $1.27 Million - $1.98 Million
281,862 Added 220.17%
409,883 $2.7 Million
Q1 2020

May 14, 2020
BUY
$2.87 - $5.49 $367,420 - $702,835
128,021 New
128,021 $595,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email